December 29, 2020
4 min watch
Save
VIDEO: ‘Exciting’ therapies in the pipeline for IBD
Issue: February 2021
In this exclusive video, Anita Afzali, MD, director of the inflammatory bowel disease center at The Ohio State University, discusses the impact of emerging therapies in IBD.
In addition to filling in some of the unmet needs in IBD care, Afzali said new therapies could help physicians provide a more personalized approach for their patients.
Published by:
Sources/Disclosures
Collapse
Source:
Healio interview
Disclosures:
Afzali reports acting as a consultant for AbbVie, Celgene, Janssen, Takeda and UCB; and receiving speaker fees from AbbVie, Janssen, Pfizer, Takeda and UCB.
Read more about